Live
- Fake currency seized from house along India-Bangladesh border in Bengal
- District Transport Officer Chinna Balu seized 15 vehicles for driving against the rules
- Won't withdraw complaint against Amanatullah Khan over non-compliance of summons: ED to Delhi court
- Awareness seminar on Sakhi services and control of child marriage
- Fortify area domination tactics to cover vulnerable areas: IGP Kashmir
- From breast cancer to brain, DNA damage - here's how ethylene oxide can affect your health
- EPFO adds 15.48 lakh net members in February as employment rises
- What's wrong if Rahul Gandhi contests from two places, Modi did it too: KC Venugopal
- Red Cross ambulatory medical services for the elderly in Lingasanipalli village
- Varun Sandesh comes with a concept-based film ‘Nindha’
Dr Reddy’s launches anti-acid drug
Dr Reddy’s launches anti-acid drug. City-based Dr Reddy\'s Laboratories on Monday said it launched a generic version of Astrazeneca\'s Nexium, used to treat acid reflux, in the US market.
.jpg)
Hyderabad: City-based Dr Reddy's Laboratories on Monday said it launched a generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US market. "It has launched Esomeprazole magnesium delayed release capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of Nexium delayed release capsules, in the US market on September 25, following approval from the US Food and Drug Administration," the company said in a release.
Citing IMS data, Dr Reddy’s said Nexium and generic had US sales of approximately $5.2 billion for most of recent 12 months ending in July, 2015. The pharma major further said Esomeprazole capsules are available in bottle count size of 30. Eesomeprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach.
